Naturally occurring tyrosinase inhibitors: Mechanism and applications in skin health, cosmetics and agriculture industries

Phytotherapy Research

Volumn 21, Issue 9, 2007, Pages 805-816

  Parvez, Shoukat ^a   Kang, Moonkyu ^b   Chung, Hwan Suck ^b   Bae, Hyunsu ^b  

^a NATIONAL INSTITUTE FOR BIOTECHNOLOGY AND GENETIC ENGINEERING NIBGE   (Pakistan)

^b Kyung Hee University   (South Korea)

Author keywords

Activators; Biochemical character; Clinical studies; Inhibitors; Tyrosinase

Indexed keywords

5 HYDROXYMETHYLFURFURAL; 9 HYDROXY 4 METHOXYPSORAIN; AGARITINE; ALOESIN; ANACARDIC ACID; ANISALDEHYDE; ANISIC ACID; ARBUTIN; AZELAIC ACID; BENZOIC ACID; CAFFEIC ACID; CINNAMALDEHYDE; CINNAMIC ACID; CUMIC ACID; CUMINALDEHYDE; DEPIGMENTING AGENT; ENZYME INHIBITOR; EPICATHECHIN 3 O GALLATE; EPIGALLOCATECHIN GALLATE; FERULIC ACID; FLAVONOID; KAEMPFEROL; KOJIC ACID; MELANIN; MONOPHENOL MONOOXYGENASE; OXYRESVERATROL; PARA COUMARIC ACID; QUERCETIN; TYROSINASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGRICULTURE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOCHEMISTRY; CANCER INHIBITION; CHEMICAL ANALYSIS; COSMETIC INDUSTRY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME SUBSTRATE; FOOD INDUSTRY; HYPERPIGMENTATION; IC 50; MELANOGENESIS; MELANOMA; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; RADIATION EXPOSURE; REVIEW; SKIN; SPECTROSCOPY; STEREOSPECIFICITY; ULTRAVIOLET RADIATION; VITILIGO;

AGRICULTURE; COSMETICS; HUMANS; PEPTIDES; PHYTOTHERAPY; PLANTS, MEDICINAL; SKIN; SKIN CARE; SKIN PIGMENTATION;

ANIMALIA; MAMMALIA;

EID: 34548614908     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2184     Document Type: Review

References (115)

1. Badria FA, el Gayyar MA. 2001. A new type of tyrosinase inhibitors from natural products as potential treatments for hyperpigmentation. Boll. Chim. Farma. 140: 267-71.
2. Baharav E, Merimski O, Shoenfeld Y et al. 1996. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105: 84-88.
3. Borges CR, Roberts JC, Wilkins DG, Rollins DE. 2001. Relationship of melanin degradation products to actual melanin content: application to human hair. Anal Biochem. 290: 116-25.
4. Bourquelot E, Bertrand A. 1895. A re-examination of the Raper's scheme: Cyclodopa as a biological precursor of eumelanin. C R Soc Biol 47: 582-584.
5. Briganti S, Camera E, Picardo M. 2003. Chemical and instrumental approaches to treat hyper-pigmentation. Pigment Cell Res 16: 101-110.
6. Burdock GA. 1995. Fenaroli's Handbook of Flavor Ingredients. CRC Press: Boca Raton, FL.
7. Burton SG. 1994. Biocatalysis with polyphenol oxidase: a review. Catal Today 22: 459-487.
8. Chen QX, Kubo I. 2002. Kinetics of mushroom tyrosinase inhibition by quercetin. J Agric Food Chem 50: 4108-4112.
9. Cohen G. 1985. Oxidative stress in the nervous system. In Oxidative Stress, Sies H (ed.). Academic Press: London, 383-401.
10. Conrad JS, Dawson SR, Hubbard ER, Meyers TE, Strothkamp KG. 1994. Inhibitor binding to the binuclear active site of tyrosinase: temperature, pH, and solvent deuterium isotope effects. Biochemistry 33: 5739-5744.
11. Cooksey CJ, Garratt PJ, Land EJ et al. 1997. Evidence of the indirect formation of the catecholic intermediate substrate responsible for the autoactivation kinetics of tyrosinase. J Biol Chem 272: 26226-26235.
12. Dawson CR, Tarpley WB. 1951. The copper oxidases. In The Enzymes, Sumner JB, Myrbäck K (eds). Academic Press: New York, 454-598.
13. Decareau RV. 1985. Microwaves in the Food Processing Industry. Academic Press: London.
14. Devece C, Rodriguez-Lopez JN, Fenoll LG, Tudela J, Catala JM, de los Reyes E, Garcia-Canovas F. 1999. Enzyme inactivation analysis for industrial blanching applications: comparison of microwave, conventional, and combination heat treatments on mushroom polyphenoloxidase activity. J. Agric. Food Chem. 47: 4506-4511.
15. Dudley ED, Hotchkiss JH. 1989. Cysteine as an inhibitor of polyphenol oxidase. J Food Biochem 13: 65-75.
16. Espín JC, García-Ruiz PA, Tudela J, García- Cánovas F. 1998. Study of stereospecificity in mushroom tyrosinase. Biochem J 331: 547-551.
17. Fenoll LG, Rodríguez-López JN, García-Sevilla F et al. 2001. Analysis and interpretation of the action mechanism of mushroom tyrosinase on monophenols and diphenols generating highly unstable o-quinone. Biochim Biophys Acta 1548: 1-22.
18. Frankos VH, Schmitt DF, Haws LC, McEvily AJ, Iyengar R, Miller SA. 1991. Generally recognised as safe (GRAS) evaluation of 4-hexylresorcinal for use as processing aid for prevention of melanosis in shrimp. Regul Toxicol Pharmacol 14: 202-212.
19. Frenk E. 1995. Treatment of melasma with depigmenting agents. In Melasma: New Approaches to Treatment. Martin Dunitz: London, 9-15.
20. Funyama M, Arakawa H, Yamamoto R, Nishino T, Shin T, Murao S. 1995. Effects of α and β arbutin on the activity of tyrosinase from mushroom and mouse melanoma. Biosci Biotechnol Biochem 59: 143-144.
21. Geotghebeur M, Kermasha S. 1996. Inhibition of polyphenol oxidase by copper-metallothionein from Aspergillus niger. Phytochemistry 42: 935-94.
22. Gerritsen YAM, Chapelon CGJ, Wichers HJ. 1994. The low-isoelectric point tyrosinase of Agaricus bisporus may be a glycoprotein. Phytochemistry 35: 573-577.
23. Golan-Goldhirsch A, Whitaker JR. 1984. Effect of ascorbic acid, sodium bisulfite, and thiol compounds on mushroom polyphenol oxidase. J Agric Food Chem 32: 1003-1009.
24. Halliwell B. 1977. Superoxide and hydroxylation reactions. In Superoxide and Superoxide Dismutases, Michelson AM, McCord JM, Fridovich I (eds). Academic Press: London, 335-349.
25. Halliwell B, Gutteridge JMC. 1984. Limited peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1: 1396-1398.
26. Han SK, Mytilineou C, Cohen G. 1996. L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66: 501-510.
27. Hepp AF, Himmelwright RS, Eickman NC, Solomon EI. 1979. Ligand displacement reactions of oxyhemocyanin: comparison of reactivities of arthropods and mollusks. Biochem Biophys Res Commun 89: 1050-1057.
28. Himmelwright RS, Eickman NC, Lu Bien CD, Lerch K, Solomon EI. 1980. Chemical and spectroscopic studies of the binuclear copper active site of Neurospora tyrosinase: Comparison to hemocyanins. J Am Chem Soc 102: 7339-7344.
29. Hsu AF, Shieh JJ, Bills DD, White K. 1988. Inhibition of mushroom polyphenoloxidase by ascorbic acid derivatives. J Food Sci 53: 765-767.
30. Husain S, Hadi SM. 1995. Strand scission in DNA induced by L-DOPA in the presence of Cu(II). FEBS Lett 364: 75-78.
31. Iyenger R, Bohmont CW, Mc Evily A. 1991. 4Hexylresorcinol and prevention of shrimp black spot: residual analysis. J Food Compos Anal 4: 148-157.
32. Jablonski N, Chaplin G. 2000. The evolution of human skin coloration. J Human Evol 39: 57-106.
33. Jackman MP, Hajnal A, Lerch K. 1991. Albino mutants of Streptomyces glaucescens tyrosinase. Biochem J 274: 707-713.
34. Jang DI, Lee BG, Jeon CO et al. 1997. Melanogenesis inhibitor from paper mulberry. Cosmetics Toiletries Magazine 112: 59.
35. Jiménez M, Chazarra S, Escribano J, Cabanes J, García-Carmona F. 2001. Competitive inhibition of mushroom tyrosinase by 4-substituted benzaldehydes. J. Agric. Food Chem. 49: 4060-4063.
36. Jiménez M, García-Carmona F. 1996. Hydrogen peroxide-dependent 4-tert-butylphenol hydroxylation by tyrosinase a new catalytic activity. Biochem Biophys Acta 1297: 33-39.
37. Jimenez M, Garcia-Carmona F. 1997. Substituted resorcinols (Sulfite alternatives) as slow binding inhibitors of Tyrosinase catecholase activity. J Agric Food Chem 45: 2061-2065.
38. Jordan AM, Khan TH, Malkin H, Osborn HMI, Photiou A, Riley P. 2001. A melanocyte-directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma. Bioorg Med Chem 9: 1549-1558.
39. Kahn V. 1995. Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine and dopamine by mushroom tyrosinase. Pigment Cell Res 8: 234-240.
40. Kahn V and Zakin V. 1995. Effect of Kojic acid on the oxidation of Trihydroxyphenols by mushroom tyrosinase. J. Food Biochem. 18: 427-443.
41. Katagiri T, Okubo T, Oyobikawa M, Futaki K, Shaku M, Kawai M. 1998. Novel melanogenic enzymes inhibitor for controlling hyperpigmentation. Paper No 7, 20th IFSCC Congress, Cannes.
42. 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol 109: 69-73.
43. Kermasha S, Goetghebeur M, Monfette A, Metchet M, Rovelt M. 1993. Inhibitory effects of cysteine and aromatic acids on tyrosinase activity. Phytochemistry 34: 349-353.
44. Kim JH, Sapers GM, Choi SW. 1998. Identification of tyrosinase inhibitor from Galla rhois. Food Sci Biotechnol 7: 56-59.
45. Kobayashi T, Vieira WD, Potterf B, Sakai C, Imokawa G. 1995. Modulation of melanogenic protein expression during the switch from eu- to phenomelanogenesis. J Cell Sci 108: 2301-2309.
46. Konanayakam M, Sastry SK. 1988. Kinetics of shrinkage of mushrooms during blanching. J Food Sci 53: 1406-1411.
47. Korner A, Pawelek J. 1982. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217: 1163-1165.
48. Kubo I, Chen QX, Nihei K. 2003. Molecular design of antibrowning agents: antioxidative tyrosinase inhibitors. Food Chem 81: 241-247.
49. Kubo I, Kinst-Hori I. 1988. Tyrosinase inhibitors from cumin. J Agric Food Chem 46: 5338-5341.
50. Kubo I, Kinst-Hori I. 1999. Flavonols from saffron flower: tyrosinase inhibitory activity and inhibition mechanism. J Agric Food Chem 47: 4121-4125.
51. Kubo I, Kinst-Hori. 1999. 2-Hydroxy-4-methoxy benzaldehyde: A potent Tyrosinase inhibitor from African medicinal plants. Planta Med 65: 19-22.
52. Kubo I, Kinst-Hori I, Kubo Y, Yamagiwa Y, Kamikawa T, Haraguchi H. 2000. Molecular design of antibrowning agents. J Agric Food Chem 48: 1393-1399.
53. Kubo I, Kinst-Hori I, Yokokawa Y. 1994. Tyrosinase inhibitors from Anacardium occidentale fruits. J Nat Prod 57: 545-551.
54. Kubo I, Yokokawa Y. 1992. Two tyrosinase inhibiting flavonol glycosides from Buddleia coriacea. Phytochemistry 31: 1075-1077.
55. Kubo I, Yokokawa Y, Kinst-Hori I. 1995. Tyrosinase inhibitors from Bolivian medicinal plants. J Nat Prod 58: 739-743.
56. Kupper U, Niedermann DM, Travaglini G, Lerch K. 1989. Isolation and characterization of the tyrosinase gene from Neurospora crassa. J Biol Chem 264: 17250-17258.
57. Kwon BS, Haq AK, Pomerantz SH, Halaban R. 1987. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 84: 7473-7477.
58. Lee HS. 2002. Tyrosinase inhibitors of Pulsatilla cernua root-derived materials. J Agric Food Chem 50: 1400-1403.
59. Lee SE, Kim MO, Lee SG, Ahn YJ, Lee HS. 2000. Inhibitory effects of Cinnamomum cassia bark-derived materials on mushroom tyrosinase. Food Sci. Biotechnol. 9: 330-333.
60. Lerch K. 1981. Copper monooxygenases: Tyrosinase and dopamine β-monooxygenase. In Metal Ions in Biological Systems, Sigel H (ed.). Dekker: New York, 143-186.
61. Lim JY, Ishiguro K, Kubo I. 1999. Tyrosinase inhibitory p-coumaric acid from ginseng leaves. Phytother Res 13: 371-375.
62. Madhosingh C, Sundberg L. 1974. Purification and properties of tyrosinase inhibitor from mushroom. FEBS Lett 49: 156-158
63. Maeda K, Fukuda M. 1996. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 276: 765-769.
64. Maeda K, Fukuda M. 1991. In vitro effectiveness of several whitening cosmetic components in human melanocytes. J Soc Cosmet Chem 42: 361-368.
65. Magnus KA, Hazes B, Ton-That H, Bonaventura C, Bonaventura J, Hol WG. 1994. Crystallographic analysis of oxygenated and deoxygenated states of arthropod hemocyanin shows unusual differences. Proteins 19: 302-309.
66. Martinez MV, Whitaker JR. 1995. The biochemistry and control of enzymatic browning. Trends Food Sci Technol 6: 195-200.
67. Mason HS, Fowlks WL, Peterson E. 1955. Oxygen transfer and electron transport by the phenolase complex. J Am Chem Soc 77: 2914-2915.
68. McEvily AJ, Iyengar R, Otwell WS. 1991. Sulfite alternative prevents shrimp melanosis. Food Technol 45: 80-86.
69. Menon S, Fleck RW, Yong G, Strothkamp KG. 1990. Benzoic acid inhibition of, β and γ isozymes of Agaricus bisporus tyrosinase. Arch Biochem Biophys 280: 27-32.
70. Morgan BDG, O Neill T, Dewey DL, Galpine AR, Riely PA. 1981. Treatment of malignant melanoma by intravascular 4-hydroxyanisole. Clin Oncol 7: 227-234.
71. Naish S, Holden JL, Cooksey CJ, Riely PA. 1988. The major primary cytotoxic product of 4-hydroxyanisole oxidation by mushroom tyrosinase is 4-methoxy ortho benzoquinone. Pigment Cell Res 1: 382-385.
72. Nishioka K. 1978. Particulate tyrosinase of human malignant melanoma. Solubilization, purification following trypsin treatment, and characterization. Eur J Biochem 85: 137-146.
73. Niwa Y, Akamatus H. 1991. Kojic acid scavenges free radicals while potentialting leukocyte functions including free radical generation. Inflammation 15: 303-315.
74. No JK, Soung DY, Kim YJ et al. 1999. Inhibition of tyrosinase by green tea components. Life Sci 65: 241-246.
75. Olivares C, Jimenez-Cervantes C, Lozano JA, Solano F, Garcia-Borron JC. 2001. The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase. Biochem J 354: 131-139.
76. Papaparaskeva-Petrides C, Ioannides C, Walker R. 1993. Contribution of phenolic and quinonoid structures in the mutagenicity of the edible mushroom. Food Chem Toxicol 31: 561-567.
77. Parrish FW, Wiley BJ, Simmons EG, Long L Jr. 1966. Production of aflatoxins and kojic acid by species of Aspergillus and Penicillium. App Microbiol 14: 139.
78. Parvez S, M Kang, Chung H-S et al. 2006. A review: survey and mechanism of skin depigmenting and lightening agents. Phytother Res 20: 921-934.
79. Piao LX, Baek SH, Park M, Park JH. 2004. Tyrsoinase-inhibitory furanocoumarin from Angelica dahurica. Biol. Pharm. Bull. 27(7): 1144-1146.
80. Pomerantz SH, Warner MC. 1967. 3,4-Dihydroxy-L-phenylalanine as the tyrosinase cofactor. Occurrence in melanoma and binding constant. J Biol Chem 242: 5308-5314.
81. Priestly GC 1993. Molecular Aspects of Dermatology. Wiley: Chichester.
82. Prota G, d'Ischia M, Mascagna D. 1994. Melanogenesis as a targeting strategy against metastatic melanoma-A reassessment. Melanoma Res 4: 351-358.
83. Raper HS. 1928. The anaerobic oxidases. Physiol Rev 8: 245-282.
84. Riely PA, Sawyer B, Wolff MA. 1975. The melanocytotoxic effect of 4-hydroxanisole. J Invest Dermatol 64: 86-89.
85. Rodriguez-Lopez JN, Tudela J, Varon R, Garcia-Cano-vas F. 1991. Kinetic study on the effect of pH on the melanin biosynthesis pathway. Biochim Biophys Acta 1076: 379-386.
86. Ros-Martinez JR, Rodríguez-López JN, Castellanos RV, García-Cánovas F. 1993. Discrimination between two kinetic mechanisms for the monophenolase activity of tyrosinase. Biochem J 294: 621-623.
87. Rouet-Mayer MA, Philippon J. 1986. Inhibition of catechol oxidases from apples by sodium chloride. Phytochemistry 25: 2717-2719.
88. Ruth H, Robin S, Patton EC, Sherri SE, Sergio T, Miriam L, Wahl SA, Daniel HN. 2002. Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway J. Biol. Chem. 17: 14821-14828.
89. Sánchez-Ferrer A, Bru R, García-Carmona F. 1990. Partial purification of a thylakoid-bound enzyme using temperature-induced phase partitioning. Anal Biochem 184: 279-282.
90. Sánchez-Ferrer A, Rodríguez-López JN, García-Cánovas F, García-Carmona F. 1995. Tyrosinase: a comprehensive review of its mechanism. Biochim Biophys Acta 1247: 1-11.
91. Sánchez-Ferrer A, Villalba J, García-Carmona F. 1989. Triton X-114 as a tool for purifying spinach polyphenol oxidase. Phytochemistry 28: 1321-1325.
92. Sanjust E, Cecchini G, Sollai F, Curreli N, Rescigno A. 2003. 3-Hydroxykynurenine as a substrate/activator for mushroom tyrosinase. Arch Biochem Biophys 412: 272-278.
93. Santerre CR, Cash JN, Vannorman DJ. 1988. Ascorbic acid/citric acid combinations in the processing of frozen apple slices. J Food Sci 53: 1713-1716.
94. Sayavecra-Soto LA, Montgomery MW. 1986. Inhibition of polyphenoloxidase by sulfite. J Food Sci 51: 1531-1536.
95. Schaffer JV, Bolognia, JL. 2001. The melanocortin-1 receptor: red hair and beyond. Arch. Dermatol. 137: 1477-85.
96. Schallreuter KU, Wood JW. 1990. A possible mechanism of action for azelaic acid in the human epidermis. Arch Dermatol Res 282: 168-171.
97. Schoot-Uiterkamp AJM, Mason HS. 1973. Magnetic dipole-dipole coupled Cu(II) pairs in nitric oxide-treated tyrosinase: A structural relationship between the active sites of tyrosinase and hemocyanin. Proc Natl Acad Sci USA 70: 993-996.
98. Seiberg M, Paine C, Sharlow et al. 2000. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 115: 162-167.
99. Seo SY, Sharma VK, Sharma N. 2003. Mushroom Tyrosinase: recent prospects, J Agric Food Chem 7;51(10): 2837-53.
100. Sharma VK, Choi J, Sharma N, Choi M, Seo S-Y. 2004. In vitro anti-tyrosinase activity of 5-(hydroxymethyl)-2-furfural isolated from Dictyophora indusiata. Phytotherapy Research 18: 841-844.
101. Shi YL, Benzie IFF, Buswell JA. 2002. Role of tyrosinase in the genoprotective effect of the edible mushroom, Agaricus bisporus. Life Sci 70: 1595-1608.
102. Shin NH, Ryu SY, Choi EJ et al. 1998. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochem Biophys Res Commun 243: 801-803.
103. Solomon EI, Sundaram UM, Machonkin TE. 1996. Multi-copper oxidases and oxygenases. Chem. Rev. 96: 2563-2605.
104. Stüssi H, Rast DM. 1981. The biosynthesis and possible function of γ-glutaminyl-4-hydroxybenzene in Agaricus bisporus. Phytochemistry 20: 2347-2352.
105. Tanford C. 1980. In The Hydrophobic Effect: Formation of Micelles and Biological Membranes. Wiley: New York.
106. Taylor SL, Bush RK. 1986. Sulfites as food ingredients. Food Technol 40: 47-52.
107. van Gelder CWG, Flurkey WH, Wichers HJ. 1997. Sequence and structural features of plant and fungal tyrosinases. Phytochemistry 45: 1309-1323.
108. Vogel FS, Kemper LA, Jeffs PW, Cass MW, Graham DG. 1977. γ-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells. Cancer Res 37: 1133-1136.
109. Volbeda A, Hoi WG. 1989. Crystal structure of hexameric haemocyanin from Panulirus interruptus refined at 3.2 A resolution. J Mol Biol 209: 249-279.
110. Wick MM, Rosowsky A, Ratliff J. 1980. Antitumor effects of L-glutamic acid dihydroxyanilides against experimental melanoma. J Invest Dermatol 74: 112-114.
111. Wilcox DE, Porras AG, Hwang YT, Lerch K, Winkler ME, Solomon EI. 1985. Substrate analogue binding to the coupled binuclear copper active site in tyrosinase. J Am Chem Soc 107: 4015-4027.
112. Wiley JW, Tyson GN, Steller JS. 1942. The configuration of complex kojates formed with some transition elements as determined by magnetic susceptibility measurements. J. Am. Chem. Soc. 64: 963-964.
113. Yagi A, Kanbara T, Morinubo N. 1987. Inhibition of Mushroom Tyrosinase by Aloe Extract. Planta Med 53: 515-517.
114. Zehtab T, Yazdanparast R, Rafiei S. 2001. Inhibition of experimental autoimmune vitiligo by oral administration of mushroom tyrosinase. Cytobios 105: 27-34.
115. Zhang X, van Leeuwen J, Wichers HJ, Flurkey WH. 1999. Characterization of tyrosinase from the cap flesh of Portabella mushrooms. J Agric Food Chem 47: 374-378.